$163 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 34 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 61.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AADI BIOSCIENCES INC | $19,622,228 | -24.9% | 1,849,402 | 0.0% | 12.08% | +7.3% | ||
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $11,581,765 | +55.7% | 396,500 | +9.3% | 7.13% | +122.4% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $11,246,925 | -70.3% | 217,500 | -60.7% | 6.92% | -57.5% |
| TERN | Buy | TERNS PHARMACEUTICALS INC | $11,198,000 | +442.0% | 1,100,000 | +213.7% | 6.89% | +674.3% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $9,176,970 | +59.4% | 33,000 | +20.0% | 5.65% | +127.7% |
| SRPT | Buy | SAREPTA TEHRAPEUTICS INC | $8,746,650 | +90.7% | 67,500 | +62.7% | 5.38% | +172.6% |
| SNDX | SYNDAX PHARMACEUTICALS INC | $8,261,426 | +5.9% | 324,614 | 0.0% | 5.08% | +51.4% | |
| ISEE | Sell | IVERIC BIO INC | $7,718,305 | -23.7% | 360,500 | -36.0% | 4.75% | +9.1% |
| Buy | VENTYX BIOSCIENCES INC | $7,558,095 | +20.3% | 290,500 | +61.4% | 4.65% | +71.9% | |
| PCVX | Buy | VAXCYTE INC | $6,928,775 | +239.6% | 144,500 | +70.0% | 4.26% | +385.6% |
| CBAY | New | CYMABAY THERAPEUTICS INC. COMMON STOCK | $6,364,050 | – | 1,015,000 | +100.0% | 3.92% | – |
| KURA | Sell | KURA ONCOLOGY INC. COMMON STOCK | $6,223,615 | -15.1% | 501,500 | -6.5% | 3.83% | +21.4% |
| MRSN | New | MERSANA THERAPEUTICS INC | $5,567,000 | – | 950,000 | +100.0% | 3.43% | – |
| BLU | Sell | BELLUS HEALTH INC | $5,199,150 | -65.8% | 632,500 | -56.0% | 3.20% | -51.1% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC | $5,125,550 | -31.8% | 115,000 | -57.0% | 3.15% | -2.5% |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $5,088,200 | – | 260,000 | +100.0% | 3.13% | – |
| BCAB | Sell | BIOATLA INC | $4,125,000 | +3.0% | 500,000 | -3.8% | 2.54% | +47.2% |
| ACRS | Buy | ACLARIS THERAPEUTICS | $4,016,250 | +58.6% | 255,000 | +58.5% | 2.47% | +126.8% |
| KROS | New | KEROS THERAPEUTICS INC | $3,841,600 | – | 80,000 | +100.0% | 2.36% | – |
| GHRS | GH RESEARCH PLCordinary shares | $2,364,390 | -16.4% | 243,250 | 0.0% | 1.46% | +19.6% | |
| ARGX | New | ARGEN SEsponsored adr | $1,932,033 | – | 5,100 | +100.0% | 1.19% | – |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS INC | $1,664,136 | -42.5% | 41,029 | -53.1% | 1.02% | -17.8% |
| FULC | Sell | FULCRUM THERAPEUTICS INC | $1,346,800 | -24.3% | 185,000 | -15.9% | 0.83% | +8.1% |
| PMVP | Sell | PMV PHARMACEUTICALS INC | $1,343,898 | -26.9% | 154,471 | -0.0% | 0.83% | +4.4% |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $1,061,886 | -55.8% | 303,396 | 0.0% | 0.65% | -36.8% | |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $981,750 | – | 93,500 | +100.0% | 0.60% | – | |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $981,753 | -33.3% | 153,639 | 0.0% | 0.60% | -4.7% | |
| PYXIS ONCOLOGY INC | $896,672 | -32.0% | 669,158 | 0.0% | 0.55% | -2.8% | ||
| RZLT | Buy | REZOLUTE INC | $869,400 | -24.3% | 420,000 | +0.2% | 0.54% | +8.3% |
| HZNP | Buy | HORIZON THERAPEUTICS PLC | $682,800 | +175.3% | 6,000 | +50.0% | 0.42% | +292.5% |
| PRTA | New | PROTHENA CORPORATION PLC | $560,325 | – | 9,300 | +100.0% | 0.34% | – |
| IMRA | New | IMARA INC | $182,017 | – | 44,503 | +100.0% | 0.11% | – |
| KNTE | KINNATE BIOPHARMA INC | $30,500 | -49.2% | 5,000 | 0.0% | 0.02% | -26.9% | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/2027 | $13,125 | -12.5% | 90,832 | 0.0% | 0.01% | +33.3% | |
| BMEA | Exit | BIOMEA FUSION INC | $0 | – | -1,000 | -100.0% | -0.00% | – |
| TRVI | Exit | TREVI THERAPEUTICS INC | $0 | – | -36,302 | -100.0% | -0.02% | – |
| NGM | Exit | NGM BIOPHARMACEUTICALS INC | $0 | – | -7,500 | -100.0% | -0.04% | – |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -5,000 | -100.0% | -0.05% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -6,700 | -100.0% | -0.06% | – | |
| SWTX | Exit | SPRINGWORKS THERAPEUTICS INC | $0 | – | -5,000 | -100.0% | -0.06% | – |
| IDYA | Exit | IDEAYA BIOSCIENCES INC | $0 | – | -10,000 | -100.0% | -0.06% | – |
| ESPR | Exit | ESPERION THERAPEUTIC | $0 | – | -30,000 | -100.0% | -0.09% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -140,000 | -100.0% | -0.29% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -192,500 | -100.0% | -0.51% | – |
| MRUS | Exit | MERUS BV | $0 | – | -59,000 | -100.0% | -0.51% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -125,000 | -100.0% | -0.69% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -290,000 | -100.0% | -1.30% | – |
| GOSS | Exit | GOSSAMER BIO INC | $0 | – | -284,500 | -100.0% | -1.47% | – |
| MIST | Exit | MILESTONE PHARMACEUTICALS IN | $0 | – | -597,026 | -100.0% | -2.36% | – |
| JYAC | Exit | JIYA ACQUISITION CORP -CL A | $0 | – | -562,500 | -100.0% | -2.42% | – |
| MRTX | Exit | MIRATI THERAPEUTICS | $0 | – | -104,800 | -100.0% | -3.15% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INCput | $0 | – | -200,000 | -100.0% | -3.19% | – |
| BLSA | Exit | BCLS ACQUISITION CORP- CL A | $0 | – | -843,122 | -100.0% | -3.64% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -272,500 | -100.0% | -4.24% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -365,618 | -100.0% | -5.83% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
| IRIDEX CORP | 20 | Q3 2019 | 8.1% |
| ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
| IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
| VERACYTE INC | 19 | Q3 2019 | 10.1% |
| ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
| XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
| CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
| APELLIS PHARMACEUTICALS INC | 17 | Q3 2023 | 18.4% |
| KURA ONCOLOGY INC. COMMON STOCK | 17 | Q3 2023 | 8.1% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
| Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
| IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
| CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.